Accessed - 415 times.

Tariq Shekh1, Asim Ali Khan1, Arun Mukharjee2, Ameeduzzafar3, Mohd Amir4, Md Manzar Alam5, Fasihuzzaman1*
1Departmen of Moalijat, Faculty of Medicine, Jamia Hamdard, Hamdard Nagar, New Delhi, India.
2Clinical Registrar, Hakeem Syed Ziaul Hasan Unani Medical College and Hospital, Government (Autonomous) Bhopal, India.
3Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi, India.
4BNP Laboratory, Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India.
5Elaj bil Tadbeer, Aligarh Unani Medical College, Aligarh, Uttar Pradesh, India.

Volume 2, Issue 1, jan-April 2014.

Article history
Received: 19 March 2014
Revised: 29 March 2014
Accepted: 03 April 2014
Early view: 28 April 2014

*Author for correspondence
Mobile/ Tel.: +91 9911256786
Warm-e-shoab muzmin

In the present study, the efficacy of a Unani formulation in chronic bronchitis was reported and provided the scientific basis on the clinical parameter. In this study, 40 patients were randomly selected into two groups. The first group (n=20) was of test study and another group (n=20) for placebo study. Both placebo and test groups were received 3 grams of sample in powder form twice daily for four weeks by the oral route. The severity of a cough, sputum, breathlessness, wheezing, peak expiratory flow rate (PEFR) and chest X-ray at the beginning and the end of treatment were assessed. The test drug showed a significant improvement as compared to placebo.